Mutagenesis of 16S rRNA C1409-G1491 base-pair differentiates between 6'OH and 6'NH3+ aminoglycosides

J Mol Biol. 2005 Feb 18;346(2):467-75. doi: 10.1016/j.jmb.2004.11.073. Epub 2004 Dec 21.

Abstract

Using a single rRNA allelic Gram-positive model system, we systematically mutagenized 16S rRNA positions 1409 and 1491 to probe the functional relevance of structural interactions between aminoglycoside antibiotics and the A-site rRNA that were suggested by X-ray crystallography. At the structural level, the interaction of the 2-deoxystreptamine aminoglycosides with the rRNA base-pair C1409-G1491 has been suggested to involve the following features: (i) ring I of the disubstituted 2-deoxystreptamines stacks upon G1491 and H-bonds to the Watson-Crick edge of A1408; (ii) ring III of the 4,5-disubstituted aminoglycosides shows hydrogen bonding to G1491. However, we found that mutants with altered 16S rRNA bases 1409 and 1491 discriminated poorly between 4,5-disubstituted and 4,6-disubstituted 2-deoxystreptamines, but differentially affected aminoglycosides with a hydroxyl group versus an ammonium group at position 6' of ring I, e.g. G1491U conferred high-level drug resistance to paromomycin and geneticin, but not to neomycin, tobramycin or gentamicin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminoglycosides / chemistry*
  • Anti-Bacterial Agents
  • Base Pairing
  • Binding Sites
  • Drug Resistance / genetics
  • Escherichia coli / cytology
  • Escherichia coli / genetics
  • Hexosamines
  • Hydrogen Bonding
  • Mutagenesis, Site-Directed*
  • Mycobacterium smegmatis / cytology
  • Mycobacterium smegmatis / genetics
  • RNA, Ribosomal, 16S / chemistry*
  • RNA, Ribosomal, 16S / genetics*
  • Substrate Specificity / genetics

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Hexosamines
  • RNA, Ribosomal, 16S
  • streptamine